Opioid Usage Toolkit

Opioid Usage Toolkit
Technology No. i750

Thank you for your interest in the Toolkit for tackling chronic opioid use in non-cancer pain.

The Medicines Optimisation Group East Anglia was supported by NIHR CLAHRC Eastern to develop an approach to opioid tapering. We combined research evidence with experiences of health organisations and practitioners to develop a programme theory. This programme theory identified seven key features that should be included in all opioid deprescribing interventions. We have formulated this evidence into a toolkit to enable effective intervention components to be adapted for diverse health systems to achieve feasibility and scalability whilst maintaining efficacy.

Downloading the toolkit and usage

Toolkit for tackling chronic opioid use in Non-Cancer Pain is licensed under a Creative Commons Attribution 4.0 International License.

You are welcome to download the Toolkit and to use it freely under terms of this licence and on condition that you let us know what you are planning to use it for. We require the details requested so that we can comply with monitoring and assessment of the impact of the work on society. For further information regarding GDPR 2018 and our Privacy Policy, please follow this link.

If you download the Toolkit now to read, then later decide to use it in a different way, for example in a health care or research setting, please come back and let us know (by answering the questions again to give us additional information).

  • swap_vertical_circlecloud_downloadSupporting documents (0)
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Creative Commons Licence for Opioid Usage Toolkit
Creative Commons Licence for Opioid Usage Toolkit

Term: perpetual

Price per unit:
£0.00 excl. VAT

Commercial licence - Opioid Usage Toolkit
Licence for use of software by commercial organisations

Term: 1 year

Price per user:
TBD

Questions about this technology?